Wednesday, February 10, 2010, 9:06am EST - Canadian Markets open in 24 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cubist Pharmaceuticals Inc. (CBST)

 On Feb 9: 20.58 USD   0.00 (0.00%)  
MORE ON CBST
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Cubist Pharmaceuticals, Inc. (NasdaqNM:CBST) Delayed quote dataEdit
Last Trade: 20.58 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 20.58
Open: N/A
Bid: 19.92 x 500
Ask: 21.09 x 1000
1y Target Est: 30.17
Day's Range: N/A - N/A
52wk Range: 13.81 - 22.39
Volume: 0
Avg Vol (3m): 623,421
Market Cap: 1.19B
P/E (ttm): 28.70
EPS (ttm): 0.72
Div & Yield: N/A (N/A%)
Cubist Pharmaceuticals Inc. (CBST)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add CBST to Portfolio   Download Data

HEADLINES
• Four Stock Ideas for a Muddled Market
at Seeking Alpha (Tue, Feb 2)
• 5-Star Stocks on the Upswing
at Motley Fool (Fri, Jan 29)
• Today's 5-Star Movers
at Motley Fool (Wed, Jan 27)
• New Star Analyst Rankings for Cubist Pharmaceuticals, Inc.
StarMine (Sat, Jan 23)
• Cubist Misses Estimate
Zacks.com (Fri, Jan 22)
• Cubist Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Thu, Jan 21)
• Cubist 4Q profit tumbles without tax benefit
AP (Thu, Jan 21)
• Cubist Pharmaceuticals Fourth Quarter 2009 Earnings Call scheduled for 5:00 pm ET today
Vcall (Thu, Jan 21)
• CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Thu, Jan 21)
• Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million
Business Wire (Thu, Jan 21)
• Q4 2009 Cubist Pharmaceuticals, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Jan 21)
• A Closer Look at Cubist Pharma
at Seeking Alpha (Thu, Jan 14)
• Correction: Cubist Revenue Outlook
AP (Wed, Jan 13)
More Headlines for CBST...
ANALYST
EPS Est (next year) (Dec-08) : 1.28
EPS Est (in 2 years) (Dec-09) : 1.71
Avg Rec (current)*: 2.2
PEG Ratio: 0.48
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cubist Pharmaceuticals, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products for the anti-infective market primarily in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices